Moreover, immunohistochemistry (IHC) and flow cytometry examination displayed that LY significantly increased the tumor infiltration of CD3+ T cells (CD45+CD3+) and CD8+ T cells (CD45+CD3+CD8+). The gene discussed is PTPRC; the disease is neoplasm.